Unimech Aerospace and Manufacturing Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report, prepared by ‘Care Ratings Limited’, details the utilization of funds raised through the company’s Initial Public Offering (IPO). This submission fulfills regulatory requirements and provides stakeholders with an update on how the IPO proceeds are being deployed.
Monitoring Agency Report Filed for Q2 2026
Unimech Aerospace and Manufacturing Limited has formally submitted its Monitoring Agency Report covering the period up to September 30, 2026. This report is in compliance with the requirements of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Findings from the Report
The monitoring agency, ‘Care Ratings Limited’, has provided an objective assessment of the utilization of funds raised from the company’s Initial Public Offering (IPO). The report confirms that the utilization of proceeds is in line with the objects disclosed in the Offer Document, with necessary shareholder and board approvals obtained for any amendments or reallocations. The report specifically notes the reallocation of certain funds towards new objects such as Mergers & Acquisitions (M&A), Greenfield Projects, and Joint Ventures, supported by shareholder approvals via postal ballot.
Financial Utilization Details
For the quarter ended September 30, 2026, the report details the progress on various objects. The company has fully utilized funds allocated for the Funding of capital expenditure for expansion through purchase of machineries and equipment (original cost ₹36.37 crore, revised ₹23.54 crore) and Funding working capital requirements (original cost ₹25.29 crore, no revision). Investments in a Material Subsidiary, including capital expenditure and funding working capital, have also seen significant utilization. A notable reallocation occurred for repayment/prepayment of certain borrowings, where the original allocation of ₹40.00 crore was revised to ₹0.00, with these funds being reallocated.
General corporate purposes (GCP) saw an increase in allocation from ₹40.65 crore to ₹41.23 crore, with ₹0.58 crore reallocated from issue expenses. The new object of M&A, Joint Ventures and Green Field Projects was allocated ₹61.29 crore, facilitated by a special resolution. Issue expenses were revised downwards to ₹18.51 crore from ₹19.09 crore, with the differential amount reallocated towards GCP.
Progress and Timelines
The report indicates that all major objects, including capital expenditure for expansion, working capital requirements, and subsidiary investments, have been fully utilized as per their revised timelines. There were no delays reported in the implementation of these objects. The company’s deployment of funds aligns with the objectives laid out in the offer document, with clear indications of progress and utilization across different segments.
The report has been considered by the Audit Committee and the Board of Directors of Unimech Aerospace and Manufacturing Limited and is being uploaded on the company’s website for public access.
Source: BSE